Literature DB >> 20653679

Risk of digoxin intoxication in heart failure patients exposed to digoxin-diuretic interactions: a population-based study.

Meng-Ting Wang1, Chen-Yi Su, Agnes L F Chan, Pei-Wen Lian, Hsin-Bang Leu, Yu-Juei Hsu.   

Abstract

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT * Increased frequency of electrolyte abnormalities and cardiac arrhythmias among patients exposed to digoxin-diuretic interactions has been well-documented in numerous descriptive studies. * Nonetheless, a clear causal relationship has not been established in these studies. WHAT THIS STUDY ADDS * The risks of digoxin intoxication associated with use of digoxin in combination with any diuretic use, types of diuretics, combinations of diuretics, and individual diuretics were quantified using a population-based nested case-control study design. * The combined therapy of digoxin with any diuretic is associated with a 3.08-fold increase in the risk of digoxin intoxication. * Regarding diuretic class, the risk carried by loop diuretics is greater than that of thiazides or potassium-sparing diuretics, and the risk varies with different combinations of diuretic classes and individual diuretics. AIMS To quantify the digoxin intoxication risk associated with exposure to digoxin-diuretic interactions, and evaluate whether the risk varies by diuretic type, individually or in combination. METHODS This was a population-based nested case-control study in which data from the National Health Insurance Research Database (NHIRD) in Taiwan were analysed. RESULTS The study cohort comprised 154 058 heart failure (HF) patients taking digoxin between 2001 and 2004, in whom digoxin intoxication requiring a hospitalization (ICD-9 code 972.1) occurred in 595 cases. A total of 28 243 matched controls were also selected for analysis. Cases were 3.08 times (adjusted OR 3.08, 95% CI 2.50, 3.79) more likely to have been prescribed diuretic medication in the previous month than controls. Regarding the class of diuretics, loop diuretics carried the greatest risk (adjusted OR 2.97, 95% CI 2.35, 3.75), followed by thiazides (OR 2.36, 95% CI 1.70, 3.29) and potassium-sparing diuretics (OR 1.72, 95% CI 0.83, 3.56). The risk was also observed to vary with different combinations of diuretics, and the loops/thiazides/potassium-sparing diuretics combination carried the greatest risk (adjusted OR 6.85, 95% CI 4.93, 9.53). Among the individual diuretics examined, hydrochlorothiazide carried the greatest risk (adjusted OR 4.63, 95% CI 2.50, 8.57). CONCLUSIONS This study provided empirical evidence that digoxin-diuretic interactions increased the risk of hospitalization for digoxin intoxication in HF patients. The risk was particularly high for concomitant use of digoxin with a combination of loop diuretics, thiazide and potassium-sparing diuretics. The combined use of digoxin and diuretics should be avoided if possible.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20653679      PMCID: PMC2911556          DOI: 10.1111/j.1365-2125.2010.03687.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  41 in total

1.  Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study.

Authors:  Peter A McCullough; Edward F Philbin; John A Spertus; Scott Kaatz; Keisha R Sandberg; W Douglas Weaver
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

Review 2.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur J Heart Fail       Date:  2008-09-16       Impact factor: 15.534

3.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Authors:  David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

4.  Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy.

Authors:  E Steiness; K H Olesen
Journal:  Br Heart J       Date:  1976-02

Review 5.  Differential pharmacokinetics of digoxin in elderly patients.

Authors:  C G Hanratty; P McGlinchey; G D Johnston; A P Passmore
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

6.  The use of anti-asthmatic medications among pediatric patients in Taiwan.

Authors:  Chi-Yu Chen; Hui-Fen Chiu; Ming-Kung Yeh; Chih-Ching Chang; Chun-Yuh Yang
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003-03       Impact factor: 2.890

Review 7.  Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure.

Authors:  K Kjeldsen; A Nørgaard; M Gheorghiade
Journal:  Cardiovasc Res       Date:  2002-09       Impact factor: 10.787

Review 8.  Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis.

Authors:  William B Hood; Antonio L Dans; Gordon H Guyatt; Roman Jaeschke; John J V McMurray
Journal:  J Card Fail       Date:  2004-04       Impact factor: 5.712

9.  Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study.

Authors:  Agnes L F Chan; Meng-Ting Wang; Chen-Yi Su; Fu-Hsiung Tsai
Journal:  Eur J Clin Pharmacol       Date:  2009-12       Impact factor: 2.953

10.  Magnesium deficiency in patients on long-term diuretic therapy for heart failure.

Authors:  P Lim; E Jacob
Journal:  Br Med J       Date:  1972-09-09
View more
  5 in total

1.  Chronic Digoxin Toxicity Leading to Institutionalization of an Elderly Woman.

Authors:  Kimberley Nix; Luiza Radu; Jason Zou; Meghan E O Vlasschaert
Journal:  Can J Hosp Pharm       Date:  2022-04-04

2.  Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study.

Authors:  Kuo-Hsuan Chung; Chung-Yi Li; Shu-Yu Kuo; Trevor Sithole; Wen-Wei Liu; Min-Huey Chung
Journal:  J Clin Sleep Med       Date:  2015-04-15       Impact factor: 4.062

3.  Risk of cancer in patients with heart failure who use digoxin: a 10-year follow-up study and cell-based verification.

Authors:  Min-Huey Chung; Yi-Wen Wang; Yung-Lung Chang; Shih-Ming Huang; Wei-Shiang Lin
Journal:  Oncotarget       Date:  2017-07-04

4.  Association between Sedative-hypnotics and Subsequent Cancer in Patients with and without Insomnia: A 14-year Follow-up Study in Taiwan.

Authors:  Hui-Fen Fang; Tzu-Yin Lee; King Cheung Hui; Howard Chi Ho Yim; Mei-Ju Chi; Min-Huey Chung
Journal:  J Cancer       Date:  2019-05-21       Impact factor: 4.207

5.  Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study.

Authors:  Maurizio Sessa; Annamaria Mascolo; Mikkel Porsborg Andersen; Giuseppe Rosano; Francesco Rossi; Annalisa Capuano; Christian Torp-Pedersen
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.